Iranian Society of Gynecology Oncology

Document Type : Original Research Article


1 School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran

2 Department of Obstetrics and Gynecology, Research Center of Fatemieh Hospital, Hamadan University of Medical Sciences Hamadan, Iran

3 Department of Obstetrics and Gynecology, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran

4 Department of Epidemiology, School of Health, Hamadan University of Medical Sciences, Hamadan, Iran

5 Department of Pathology, Hamadan University of Medical Sciences, Hamadan, Iran


Background: The purpose of the current study is to compare the diagnosis of gynecologic cancer before and after the COVID-19 pandemic in Fatemieh Hospital, Hamedan from 2018 to 2021, and finally to diagnose the effect of the COVID-19 pandemic on gynecologic cancer.
Methods: This quantitative-descriptive study was done from 2018 to 2021 in the oncology clinic of Fatemieh Hospital, Hamedan. The sample was selected from the medical records of female patients who visited the oncology clinic of Fatmieh Hospital, Hamedan.
Results: Based on the results, it was made clear that most examined patients were afflicted with ovarian cancer. The number of times that patients visited the hospital decreased after the COVID-19 pandemic, and more patients with symptoms of gynecologic cancer visited the hospital than before the outbreak. After the outbreak of the COVID-19 pandemic, patients visited the hospital with more symptoms of malignant disease complaining about abnormal bleeding, and in the medical examination, they had more obvious lumps/tumors.
Conclusion: The result of our study showed that the COVID-19 epidemic decreased the number of times patients afflicted with gynecologic cancer visited this health center, and consequently their symptoms became much more severe.


Main Subjects

1. Ramirez PT, Chiva L, Eriksson AGZ, Frumovitz M, Fagotti A, Gonzalez Martin A, et al. COVID-19 Global Pandemic: Options for Management of Gynecologic Cancers. Int J Gynecol Cancer. 2020;30(5):561-3. [DOI:10.1136/ijgc-2020-001419] [PMID]
2. Han J, Yin J, Wu X, Wang D, Li C. Environment and COVID-19 incidence: A critical review. J Environ Sci (China). 2023;124:933-51. [DOI:10.1016/j.jes.2022.02.016] [PMID] [PMCID]
3. Arun Babu S, Arun Babu T. Challenges in the diagnosis and treatment of gynecological cancers during the COVID-19 pandemic. Cancer Res Stat Treat. 2020;3:611-2. [DOI:10.4103/CRST.CRST_273_20]
4. Uwins C, Bhandoria GP, Shylasree TS, Butler-Manuel S, Ellis P, Chatterjee J, et al. COVID-19 and gynecological cancer: a review of the published guidelines. Int J Gynecol Cancer. 2020;30(9):1424-33. [DOI:10.1136/ijgc-2020-001634] [PMID]
5. Kraft H, Weiss F. Pandemic portfolio choice. Eur J Oper Res. 2023;305(1):451-62. [DOI:10.1016/j.ejor.2022.05.035] [PMID] [PMCID]
6. Aljowaie RM, Andleeb S, Kangal A, Al-Ghamdi AA, Rehman KU, Javed R, et al. Prospect of herbal medication as prevention against COVID variants. J King Saud Univ Sci. 2023;35(1):102360. [DOI:10.1016/j.jksus.2022.102360] [PMID] [PMCID]
7. Tsibulak I, Reiser E, Bogner G, Petru E, Hell-Teutsch J, Reinthaller A, et al. Decrease in gynecological cancer diagnoses during the COVID-19 pandemic: an Austrian perspective. Int J Gynecol Cancer. 2020;30(11):1667-71. [DOI:10.1136/ijgc-2020-001975] [PMID] [PMCID]
8. Vrdoljak E, Balja MP, Marušić Z, Avirović M, Blažičević V, Tomasović Č, et al. COVID-19 Pandemic Effects on Breast Cancer Diagnosis in Croatia: A Population- and Registry-Based Study. Oncologist. 2021;26(7):e1156-e60. [DOI:10.1002/onco.13791] [PMID] [PMCID]
9. Knoll K, Reiser E, Leitner K, Kögl J, Ebner C, Marth C, Tsibulak I. The impact of COVID-19 pandemic on the rate of newly diagnosed gynecological and breast cancers: a tertiary center perspective. Arch Gynecol Obstet. 2022;305(4):945-53. [DOI:10.1007/s00404-021-06259-5] [PMID] [PMCID]
10. Bravaccini S, Nicolini F, Zanoni M, Gaimari A, Cerchione C, Maltoni R, et al. Why the complications of COVID-19 patients differ in elderly and young cancer patients. Transl Oncol. 2022;26:101541. [DOI:10.1016/j.tranon.2022.101541] [PMID] [PMCID]
11. Bertoni L, Roncadori A, Gentili N, Danesi V, Massa I, Nanni O, et al. How has COVID-19 pandemic changed flu vaccination attitudes among an Italian cancer center healthcare workers? Hum Vaccin Immunother. 2022;18(1):1978795. [DOI:10.1080/21645515.2021.1978795] [PMID] [PMCID]
12. Wang Z, Wang J, He J. Active and Effective Measures for the Care of Patients With Cancer During the COVID-19 Spread in China. JAMA. 2020;6(5):631-2. [DOI:10.1001/jamaoncol.2020.1198] [PMID]
13. Maringe C, Spicer J, Morris M, Purushotham A, Nolte E, Sullivan R, et al. The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study. Lancet Oncol. 2020;21(8):1023-34. [DOI:10.1016/S1470-2045(20)30388-0] [PMID]
14. Hamilton W. Cancer diagnostic delay in the COVID-19 era: what happens next? Lancet Oncol. 2020;21(8):1000-2. [DOI:10.1016/S1470-2045(20)30391-0] [PMID]
15. Bhatla N, Singhal S. The COVID-19 Pandemic and Implications for Gynaecologic Cancer Care. Indian J Gynecol Oncol. 2020;18(2):48. [DOI:10.1007/s40944-020-00395-7] [PMID] [PMCID]
16. DeGroff A, Miller J, Sharma K, Sun J, Helsel W, Kammerer W, et al. COVID-19 impact on screening test volume through the National Breast and Cervical Cancer early detection program, January-June 2020, in the United States. Prev Med. 2021;151:106559. [DOI:10.1016/j.ypmed.2021.106559] [PMID] [PMCID]
17. Arab M, Noghabaei G. Comparison of Age- Standard Incidence Rate Trends of Gynecologic and Breast Cancer in Iran and Other Countries. Iran J Public Health. 2014;43(10):1372-9.
18. Sargazi N, Daroudi R, Zendehdel K, Hashemi FA, Tahmasebi M, Darrudi A, Nahvijou A. Economic Burden of Gynecological Cancers in Iran. Value Health Reg Issues. 2022;28:1-6. [DOI:10.1016/j.vhri.2021.02.005] [PMID]
19. Frey MK, Ellis AE, Zeligs K, Chapman-Davis E, Thomas C, Christos PJ, et al. Impact of the coronavirus disease 2019 pandemic on the quality of life for women with ovarian cancer. Am J Obstet Gynecol. 2020;223(5):725.e1-.e9. [DOI:10.1016/j.ajog.2020.06.049] [PMID] [PMCID]
20. Bonadio RC, Messias AP, Moreira OA, Leis LV, Orsi BZ, Testa L, Estevez-Diz MDP. Impact of the COVID-19 pandemic on breast and cervical cancer stage at diagnosis in Brazil. Ecancermedicalscience. 2021;15:1299. [DOI:10.3332/ecancer.2021.1299] [PMID] [PMCID]
21. Dinmohamed AG, Visser O, Verhoeven RHA, Louwman MWJ, van Nederveen FH, Willems SM, et al. Fewer cancer diagnoses during the COVID-19 epidemic in the Netherlands. Lancet Oncol. 2020;21(6):750-1. [DOI:10.1016/S1470-2045(20)30265-5] [PMID]
22. Kaufman HW, Chen Z, Niles J, Fesko Y. Changes in the Number of US Patients With Newly Identified Cancer Before and During the Coronavirus Disease 2019 (COVID-19) Pandemic. JAMA. 2020;3(8):e2017267. [DOI:10.1001/jamanetworkopen.2020.17267] [PMID] [PMCID]
23. Davies JM, Spencer A, Macdonald S, Dobson L, Haydock E, Burton H, et al. Cervical cancer and COVID-an assessment of the initial effect of the pandemic and subsequent projection of impact for women in England: A cohort study. BJOG. 2022;129(7):1133-9. [DOI:10.1111/1471-0528.17098] [PMID] [PMCID]
24. Kuzuu K, Misawa N, Ashikari K, Kessoku T, Kato S, Hosono K, et al. Gastrointestinal Cancer Stage at Diagnosis Before and During the COVID-19 Pandemic in Japan. JAMA. 2021;4(9):e2126334. [DOI:10.1001/jamanetworkopen.2021.26334] [PMID] [PMCID]
25. Hashemi SR, Akbari MR, Soleimani Z. Histopathological Study of Gynecological Cancers in Patients Admitted to Baqiyatallah Hospital in Tehran during 2011-2019. Avicenna J Med Biochem. 2021;28(1):42-8. [DOI:10.52547/ajcm.28.1.42]